{"doi":"10.1371/journal.pbio.3002118","title":"Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England","abstract":"<jats:p>The relationship between prevalence of infection and severe outcomes such as hospitalisation and death changed over the course of the COVID-19 pandemic. Reliable estimates of the infection fatality ratio (IFR) and infection hospitalisation ratio (IHR) along with the time-delay between infection and hospitalisation/death can inform forecasts of the numbers/timing of severe outcomes and allow healthcare services to better prepare for periods of increased demand. The REal-time Assessment of Community Transmission-1 (REACT-1) study estimated swab positivity for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in England approximately monthly from May 2020 to March 2022. Here, we analyse the changing relationship between prevalence of swab positivity and the IFR and IHR over this period in England, using publicly available data for the daily number of deaths and hospitalisations, REACT-1 swab positivity data, time-delay models, and Bayesian P-spline models. We analyse data for all age groups together, as well as in 2 subgroups: those aged 65 and over and those aged 64 and under. Additionally, we analysed the relationship between swab positivity and daily case numbers to estimate the case ascertainment rate of England’s mass testing programme. During 2020, we estimated the IFR to be 0.67% and the IHR to be 2.6%. By late 2021/early 2022, the IFR and IHR had both decreased to 0.097% and 0.76%, respectively. The average case ascertainment rate over the entire duration of the study was estimated to be 36.1%, but there was some significant variation in continuous estimates of the case ascertainment rate. Continuous estimates of the IFR and IHR of the virus were observed to increase during the periods of Alpha and Delta’s emergence. During periods of vaccination rollout, and the emergence of the Omicron variant, the IFR and IHR decreased. During 2020, we estimated a time-lag of 19 days between hospitalisation and swab positivity, and 26 days between deaths and swab positivity. By late 2021/early 2022, these time-lags had decreased to 7 days for hospitalisations and 18 days for deaths. Even though many populations have high levels of immunity to SARS-CoV-2 from vaccination and natural infection, waning of immunity and variant emergence will continue to be an upwards pressure on the IHR and IFR. As investments in community surveillance of SARS-CoV-2 infection are scaled back, alternative methods are required to accurately track the ever-changing relationship between infection, hospitalisation, and death and hence provide vital information for healthcare provision and utilisation.</jats:p>","journal":"PLOS Biology","year":2023,"id":644276,"datarank":0.952899339717717,"base_score":3.6888794541139363,"endowment":3.6888794541139363,"self_citation_contribution":0.5533319181170905,"citation_network_contribution":0.39956742160062647,"self_endowment_contribution":0.5533319181170905,"citer_contribution":0.39956742160062647,"corpus_percentile":null,"corpus_rank":null,"citation_count":39,"citer_count":24,"citers_with_citation_signal":15,"citers_with_endowment":15,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1304437,"name":"David Haw","orcid":"0000-0002-9228-0542","position":1,"is_corresponding":false},{"id":293200,"name":"Haowei Wang","orcid":"0000-0001-9197-8730","position":2,"is_corresponding":false},{"id":1676831,"name":"Christina Atchison","orcid":null,"position":3,"is_corresponding":false},{"id":39993,"name":"Deborah Ashby","orcid":"0000-0003-3146-7466","position":4,"is_corresponding":false},{"id":83830,"name":"Graham S. Cooke","orcid":null,"position":5,"is_corresponding":false},{"id":1676832,"name":"Wendy Barclay","orcid":null,"position":6,"is_corresponding":false},{"id":705322,"name":"Helen Ward","orcid":"0000-0001-8238-5036","position":7,"is_corresponding":false},{"id":12807,"name":"Ara Darzi","orcid":"0000-0001-7815-7989","position":8,"is_corresponding":false},{"id":61115,"name":"Christl A. Donnelly","orcid":"0000-0002-0195-2463","position":9,"is_corresponding":false},{"id":215241,"name":"Marc Chadeau-Hyam","orcid":null,"position":10,"is_corresponding":false},{"id":1334014,"name":"Paul Elliott","orcid":"0009-0000-8749-3327","position":11,"is_corresponding":false},{"id":339533,"name":"Steven Riley","orcid":"0000-0001-7904-4804","position":12,"is_corresponding":false},{"id":1676830,"name":"Oliver Eales","orcid":"0000-0002-8086-4495","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England","abstract":"<jats:p>The relationship between prevalence of infection and severe outcomes such as hospitalisation and death changed over the course of the COVID-19 pandemic. Reliable estimates of the infection fatality ratio (IFR) and infection hospitalisation ratio (IHR) along with the time-delay between infection and hospitalisation/death can inform forecasts of the numbers/timing of severe outcomes and allow healthcare services to better prepare for periods of increased demand. The REal-time Assessment of Community Transmission-1 (REACT-1) study estimated swab positivity for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in England approximately monthly from May 2020 to March 2022. Here, we analyse the changing relationship between prevalence of swab positivity and the IFR and IHR over this period in England, using publicly available data for the daily number of deaths and hospitalisations, REACT-1 swab positivity data, time-delay models, and Bayesian P-spline models. We analyse data for all age groups together, as well as in 2 subgroups: those aged 65 and over and those aged 64 and under. Additionally, we analysed the relationship between swab positivity and daily case numbers to estimate the case ascertainment rate of England’s mass testing programme. During 2020, we estimated the IFR to be 0.67% and the IHR to be 2.6%. By late 2021/early 2022, the IFR and IHR had both decreased to 0.097% and 0.76%, respectively. The average case ascertainment rate over the entire duration of the study was estimated to be 36.1%, but there was some significant variation in continuous estimates of the case ascertainment rate. Continuous estimates of the IFR and IHR of the virus were observed to increase during the periods of Alpha and Delta’s emergence. During periods of vaccination rollout, and the emergence of the Omicron variant, the IFR and IHR decreased. During 2020, we estimated a time-lag of 19 days between hospitalisation and swab positivity, and 26 days between deaths and swab positivity. By late 2021/early 2022, these time-lags had decreased to 7 days for hospitalisations and 18 days for deaths. Even though many populations have high levels of immunity to SARS-CoV-2 from vaccination and natural infection, waning of immunity and variant emergence will continue to be an upwards pressure on the IHR and IFR. As investments in community surveillance of SARS-CoV-2 infection are scaled back, alternative methods are required to accurately track the ever-changing relationship between infection, hospitalisation, and death and hence provide vital information for healthcare provision and utilisation.</jats:p>","is_dataset_classified":null,"base_score":3.6888794541139363,"endowment":3.6888794541139363,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"37228015","pmcid":"PMC10212114","openalex_id":"https://openalex.org/W4378211593","authors":[],"funders":[{"funder_name":"Wellcome Trust","grant_id":"200861/Z/16/Z, 200187/Z/15/Z","title":null},{"funder_name":"Centres for Disease Control and Prevention","grant_id":"US, U01CK0005-01-02","title":null},{"funder_name":"National Institute for Health Research","grant_id":"Professorship","title":null},{"funder_name":"National Institute for Health Research","grant_id":"Senior Investigator Award","title":null},{"funder_name":"Wellcome Trust","grant_id":"205456/Z/16/Z","title":null},{"funder_name":"MRC Centre for Environment and Health","grant_id":"MR/L01341X/1, MR/S019669/1","title":null},{"funder_name":"Health Data Research UK","grant_id":"HDR UK","title":null},{"funder_name":"British Heart Foundation Centre for Research Excellence","grant_id":"RE/18/4/34215","title":null},{"funder_name":"UK Dementia Research Institute","grant_id":"MC_PC_17114","title":"Capital award for UK DRI at Imperial College London"},{"funder_name":"Cancer Research UK","grant_id":"22184","title":null},{"funder_name":"H2020-EXPANSE","grant_id":"Horizon 2020 grant No 874627","title":null},{"funder_name":"H2020-LongITools","grant_id":"Horizon 2020 grant No 874739","title":null},{"funder_name":"Medical Research Council","grant_id":" MR/S019669/1","title":"MRC Centre for Environment and Health"},{"funder_name":"Wellcome Trust","grant_id":"200861/Z/16/Z","title":null},{"funder_name":"Medical Research Council","grant_id":"MR/L01341X/1","title":"MRC-PHE Centre for Environment and Health"},{"funder_name":"Wellcome Trust","grant_id":"200187/Z/15/Z","title":null},{"funder_name":"Medical Research Council","grant_id":"MR/R015600/1","title":null},{"funder_name":"National Institute for Health Research (NIHR)","grant_id":"RP-2016-07-012","title":null},{"funder_name":"European Commission","grant_id":"874739","title":"Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases"},{"funder_name":"European Commission","grant_id":"874627","title":"EXposome Powered tools for healthy living  in urbAN SEttings"},{"funder_name":"Wellcome Trust","grant_id":"200861","title":"The life course of human immune responses to influenza infection and vaccination"},{"funder_name":"Wellcome Trust","grant_id":"200187","title":"The evolution of influenza virus: studies of within host and between host evolution to improve pandemic risk assessment and vaccine updates."},{"funder_name":"Wellcome Trust","grant_id":"205456","title":"‘People like you’: contemporary figures of personalisation"},{"funder_name":"NIHR Imperial Biomedical Research Centre","grant_id":"","title":null},{"funder_name":"National Institute for Health Research (NIHR)","grant_id":"","title":null},{"funder_name":"The Huo Family Foundation","grant_id":"","title":null},{"funder_name":"Medical Research Council","grant_id":"","title":null},{"funder_name":"NIHR HPRU in Chemical and Radiation Threats and Hazards, and Environmental Exposures and Health","grant_id":"","title":null}],"total_grants":28,"fwci":6.9353,"citation_percentile":0.98256017,"influential_citations":0,"citation_trend":[{"year":2023,"count":5},{"year":2024,"count":13},{"year":2025,"count":14},{"year":2026,"count":7}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3002118&type=printable","host_type":"journal"},{"url":"https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3002118&type=printable","host_type":"publisher"},{"url":"https://dx.plos.org/10.1371/journal.pbio.3002118","host_type":"publisher"},{"url":"https://doi.org/10.1371/journal.pbio.3002118","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/37228015","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10212114","host_type":"repository"},{"url":"http://hdl.handle.net/10044/1/104617","host_type":"repository"},{"url":"https://doaj.org/article/46ccc2a69bdb4ab2963f183489d1b788","host_type":"repository"},{"url":"https://doaj.org/article/569a7bb11fe64ee28b6c7fb395e8eee0","host_type":"repository"},{"url":"https://ora.ox.ac.uk/objects/uuid:029c82ea-39a6-4bb2-a4b6-91b0b039f5aa","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10212114/pdf/pbio.3002118.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC10212114","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC10212114?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1371/journal.pbio.3002118","host_type":""},{"url":"https://espace.library.uq.edu.au/view/UQ:918274c","host_type":""},{"url":"https://api.library.uq.edu.au/view/UQ:918274c","host_type":""},{"url":"https://doi.org/https://doi.org/10.1371/journal.pbio.3002118","host_type":""}],"fields_of_study":["COVID-19 epidemiological studies","COVID-19 Clinical Research Studies","SARS-CoV-2 and COVID-19 Research","0303 health sciences","03 medical and health sciences"],"mesh_terms":["COVID-19","SARS-CoV-2","Bayes Theorem","England","Hospitalization","Humans","Pandemics"],"keywords":["Case fatality rate","Pandemic","Demography","Coronavirus disease 2019 (COVID-19)","Transmission (telecommunications)","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Medicine","Epidemiology","Pediatrics","Biology","Internal medicine","Disease","Infectious disease (medical specialty)","QH301-705.5","SARS-CoV-2","COVID-19","Bayes Theorem","613","Hospitalization","England","616","Humans","Biology (General)","Pandemics","Research Article"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-09T00:47:56.186542Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}